nodes	percent_of_prediction	percent_of_DWPC	metapath
Guanfacine—hypertension—obesity	0.297	1	CtDrD
Guanfacine—attention deficit hyperactivity disorder—Bupropion—obesity	0.14	0.5	CpDpCtD
Guanfacine—attention deficit hyperactivity disorder—Methamphetamine—obesity	0.14	0.5	CpDpCtD
Guanfacine—Phenacemide—Phentermine—obesity	0.0827	0.529	CrCrCtD
Guanfacine—Phenacemide—Methamphetamine—obesity	0.0737	0.471	CrCrCtD
Guanfacine—ADRA2B—Methamphetamine—obesity	0.0333	0.183	CbGbCtD
Guanfacine—ADRA2A—Benzphetamine—obesity	0.029	0.159	CbGbCtD
Guanfacine—ADRA2A—Phenylpropanolamine—obesity	0.0276	0.152	CbGbCtD
Guanfacine—ADRA2A—Methamphetamine—obesity	0.0231	0.127	CbGbCtD
Guanfacine—CYP2C9—Phentermine—obesity	0.0105	0.0578	CbGbCtD
Guanfacine—CYP2C9—Bupropion—obesity	0.00895	0.0492	CbGbCtD
Guanfacine—CYP3A4—Sibutramine—obesity	0.00808	0.0444	CbGbCtD
Guanfacine—CYP2C19—Cimetidine—obesity	0.00791	0.0434	CbGbCtD
Guanfacine—CYP2C9—Cimetidine—obesity	0.00657	0.0361	CbGbCtD
Guanfacine—CYP3A4—Benzphetamine—obesity	0.00612	0.0336	CbGbCtD
Guanfacine—CYP3A4—Bupropion—obesity	0.00521	0.0286	CbGbCtD
Guanfacine—CYP2C19—Topiramate—obesity	0.00517	0.0284	CbGbCtD
Guanfacine—CYP3A4—Orlistat—obesity	0.00424	0.0233	CbGbCtD
Guanfacine—CYP3A4—Cimetidine—obesity	0.00382	0.021	CbGbCtD
Guanfacine—CYP3A4—Topiramate—obesity	0.0025	0.0137	CbGbCtD
Guanfacine—Cramps of lower extremities—Topiramate—obesity	0.000101	0.00177	CcSEcCtD
Guanfacine—Rash—Phentermine—obesity	0.000101	0.00176	CcSEcCtD
Guanfacine—Dermatitis—Phentermine—obesity	0.000101	0.00176	CcSEcCtD
Guanfacine—Headache—Phentermine—obesity	0.0001	0.00175	CcSEcCtD
Guanfacine—Pollakiuria—Bupropion—obesity	0.0001	0.00175	CcSEcCtD
Guanfacine—Erectile dysfunction—Bupropion—obesity	9.99e-05	0.00175	CcSEcCtD
Guanfacine—Rhinitis—Sibutramine—obesity	9.99e-05	0.00175	CcSEcCtD
Guanfacine—Nausea—Phenylpropanolamine—obesity	9.93e-05	0.00174	CcSEcCtD
Guanfacine—Weight increased—Bupropion—obesity	9.87e-05	0.00173	CcSEcCtD
Guanfacine—Hypersensitivity—Cimetidine—obesity	9.76e-05	0.00171	CcSEcCtD
Guanfacine—Visual impairment—Sibutramine—obesity	9.6e-05	0.00168	CcSEcCtD
Guanfacine—Acute coronary syndrome—Bupropion—obesity	9.54e-05	0.00167	CcSEcCtD
Guanfacine—Diarrhoea—Diethylpropion—obesity	9.52e-05	0.00166	CcSEcCtD
Guanfacine—Nausea—Phentermine—obesity	9.5e-05	0.00166	CcSEcCtD
Guanfacine—Asthenia—Cimetidine—obesity	9.5e-05	0.00166	CcSEcCtD
Guanfacine—Myocardial infarction—Bupropion—obesity	9.48e-05	0.00166	CcSEcCtD
Guanfacine—Conjunctivitis—Bupropion—obesity	9.4e-05	0.00164	CcSEcCtD
Guanfacine—Eye disorder—Sibutramine—obesity	9.31e-05	0.00163	CcSEcCtD
Guanfacine—Immune system disorder—Orlistat—obesity	9.3e-05	0.00162	CcSEcCtD
Guanfacine—Tinnitus—Sibutramine—obesity	9.29e-05	0.00162	CcSEcCtD
Guanfacine—Sweating—Bupropion—obesity	9.27e-05	0.00162	CcSEcCtD
Guanfacine—Dizziness—Diethylpropion—obesity	9.2e-05	0.00161	CcSEcCtD
Guanfacine—Alopecia—Orlistat—obesity	9.09e-05	0.00159	CcSEcCtD
Guanfacine—Diarrhoea—Cimetidine—obesity	9.06e-05	0.00158	CcSEcCtD
Guanfacine—Immune system disorder—Sibutramine—obesity	9e-05	0.00157	CcSEcCtD
Guanfacine—Vascular purpura—Topiramate—obesity	8.94e-05	0.00156	CcSEcCtD
Guanfacine—Vomiting—Diethylpropion—obesity	8.85e-05	0.00155	CcSEcCtD
Guanfacine—Alopecia—Sibutramine—obesity	8.8e-05	0.00154	CcSEcCtD
Guanfacine—Rash—Diethylpropion—obesity	8.78e-05	0.00153	CcSEcCtD
Guanfacine—Dysgeusia—Orlistat—obesity	8.77e-05	0.00153	CcSEcCtD
Guanfacine—Dermatitis—Diethylpropion—obesity	8.77e-05	0.00153	CcSEcCtD
Guanfacine—Dizziness—Cimetidine—obesity	8.76e-05	0.00153	CcSEcCtD
Guanfacine—Headache—Diethylpropion—obesity	8.72e-05	0.00152	CcSEcCtD
Guanfacine—Rhinitis—Bupropion—obesity	8.71e-05	0.00152	CcSEcCtD
Guanfacine—Hallucination—Bupropion—obesity	8.64e-05	0.00151	CcSEcCtD
Guanfacine—Muscle spasms—Orlistat—obesity	8.61e-05	0.00151	CcSEcCtD
Guanfacine—Amnesia—Topiramate—obesity	8.51e-05	0.00149	CcSEcCtD
Guanfacine—Tension—Sibutramine—obesity	8.51e-05	0.00149	CcSEcCtD
Guanfacine—Dysgeusia—Sibutramine—obesity	8.49e-05	0.00148	CcSEcCtD
Guanfacine—Vision blurred—Orlistat—obesity	8.44e-05	0.00148	CcSEcCtD
Guanfacine—Nervousness—Sibutramine—obesity	8.42e-05	0.00147	CcSEcCtD
Guanfacine—Vomiting—Cimetidine—obesity	8.42e-05	0.00147	CcSEcCtD
Guanfacine—Visual impairment—Bupropion—obesity	8.37e-05	0.00146	CcSEcCtD
Guanfacine—Rash—Cimetidine—obesity	8.35e-05	0.00146	CcSEcCtD
Guanfacine—Dermatitis—Cimetidine—obesity	8.34e-05	0.00146	CcSEcCtD
Guanfacine—Muscle spasms—Sibutramine—obesity	8.34e-05	0.00146	CcSEcCtD
Guanfacine—Ill-defined disorder—Orlistat—obesity	8.31e-05	0.00145	CcSEcCtD
Guanfacine—Headache—Cimetidine—obesity	8.3e-05	0.00145	CcSEcCtD
Guanfacine—Purpura—Topiramate—obesity	8.3e-05	0.00145	CcSEcCtD
Guanfacine—Nausea—Diethylpropion—obesity	8.27e-05	0.00145	CcSEcCtD
Guanfacine—Vision blurred—Sibutramine—obesity	8.17e-05	0.00143	CcSEcCtD
Guanfacine—Lethargy—Topiramate—obesity	8.16e-05	0.00143	CcSEcCtD
Guanfacine—Tremor—Sibutramine—obesity	8.12e-05	0.00142	CcSEcCtD
Guanfacine—Eye disorder—Bupropion—obesity	8.12e-05	0.00142	CcSEcCtD
Guanfacine—Tinnitus—Bupropion—obesity	8.1e-05	0.00142	CcSEcCtD
Guanfacine—Malaise—Orlistat—obesity	8.08e-05	0.00141	CcSEcCtD
Guanfacine—Vertigo—Orlistat—obesity	8.05e-05	0.00141	CcSEcCtD
Guanfacine—Ill-defined disorder—Sibutramine—obesity	8.05e-05	0.00141	CcSEcCtD
Guanfacine—Pain in extremity—Topiramate—obesity	8e-05	0.0014	CcSEcCtD
Guanfacine—Agitation—Sibutramine—obesity	7.97e-05	0.00139	CcSEcCtD
Guanfacine—Palpitations—Orlistat—obesity	7.92e-05	0.00138	CcSEcCtD
Guanfacine—Affect lability—Topiramate—obesity	7.87e-05	0.00138	CcSEcCtD
Guanfacine—Nausea—Cimetidine—obesity	7.87e-05	0.00138	CcSEcCtD
Guanfacine—Immune system disorder—Bupropion—obesity	7.84e-05	0.00137	CcSEcCtD
Guanfacine—Malaise—Sibutramine—obesity	7.82e-05	0.00137	CcSEcCtD
Guanfacine—Vertigo—Sibutramine—obesity	7.79e-05	0.00136	CcSEcCtD
Guanfacine—Syncope—Sibutramine—obesity	7.78e-05	0.00136	CcSEcCtD
Guanfacine—Convulsion—Orlistat—obesity	7.76e-05	0.00136	CcSEcCtD
Guanfacine—Alopecia—Bupropion—obesity	7.67e-05	0.00134	CcSEcCtD
Guanfacine—Palpitations—Sibutramine—obesity	7.66e-05	0.00134	CcSEcCtD
Guanfacine—Irritability—Topiramate—obesity	7.63e-05	0.00133	CcSEcCtD
Guanfacine—Chest pain—Orlistat—obesity	7.63e-05	0.00133	CcSEcCtD
Guanfacine—Myalgia—Orlistat—obesity	7.63e-05	0.00133	CcSEcCtD
Guanfacine—Loss of consciousness—Sibutramine—obesity	7.62e-05	0.00133	CcSEcCtD
Guanfacine—Anxiety—Orlistat—obesity	7.6e-05	0.00133	CcSEcCtD
Guanfacine—Discomfort—Orlistat—obesity	7.54e-05	0.00132	CcSEcCtD
Guanfacine—Convulsion—Sibutramine—obesity	7.51e-05	0.00131	CcSEcCtD
Guanfacine—Hypertension—Sibutramine—obesity	7.49e-05	0.00131	CcSEcCtD
Guanfacine—Dry mouth—Orlistat—obesity	7.46e-05	0.0013	CcSEcCtD
Guanfacine—Tension—Bupropion—obesity	7.42e-05	0.0013	CcSEcCtD
Guanfacine—Dysgeusia—Bupropion—obesity	7.4e-05	0.00129	CcSEcCtD
Guanfacine—Liver function test abnormal—Topiramate—obesity	7.38e-05	0.00129	CcSEcCtD
Guanfacine—Arthralgia—Sibutramine—obesity	7.38e-05	0.00129	CcSEcCtD
Guanfacine—Myalgia—Sibutramine—obesity	7.38e-05	0.00129	CcSEcCtD
Guanfacine—Chest pain—Sibutramine—obesity	7.38e-05	0.00129	CcSEcCtD
Guanfacine—Anxiety—Sibutramine—obesity	7.36e-05	0.00129	CcSEcCtD
Guanfacine—Nervousness—Bupropion—obesity	7.34e-05	0.00128	CcSEcCtD
Guanfacine—Oedema—Orlistat—obesity	7.31e-05	0.00128	CcSEcCtD
Guanfacine—Orthostatic hypotension—Topiramate—obesity	7.3e-05	0.00128	CcSEcCtD
Guanfacine—Abdominal pain upper—Topiramate—obesity	7.3e-05	0.00128	CcSEcCtD
Guanfacine—Discomfort—Sibutramine—obesity	7.29e-05	0.00127	CcSEcCtD
Guanfacine—Muscle spasms—Bupropion—obesity	7.27e-05	0.00127	CcSEcCtD
Guanfacine—Dry mouth—Sibutramine—obesity	7.22e-05	0.00126	CcSEcCtD
Guanfacine—Confusional state—Sibutramine—obesity	7.14e-05	0.00125	CcSEcCtD
Guanfacine—Vision blurred—Bupropion—obesity	7.12e-05	0.00125	CcSEcCtD
Guanfacine—Tremor—Bupropion—obesity	7.08e-05	0.00124	CcSEcCtD
Guanfacine—Oedema—Sibutramine—obesity	7.08e-05	0.00124	CcSEcCtD
Guanfacine—Hyperhidrosis—Orlistat—obesity	7.07e-05	0.00124	CcSEcCtD
Guanfacine—Alanine aminotransferase increased—Topiramate—obesity	7.05e-05	0.00123	CcSEcCtD
Guanfacine—Ill-defined disorder—Bupropion—obesity	7.01e-05	0.00123	CcSEcCtD
Guanfacine—Shock—Sibutramine—obesity	6.96e-05	0.00122	CcSEcCtD
Guanfacine—Agitation—Bupropion—obesity	6.95e-05	0.00121	CcSEcCtD
Guanfacine—Asthma—Topiramate—obesity	6.91e-05	0.00121	CcSEcCtD
Guanfacine—Dysphagia—Topiramate—obesity	6.91e-05	0.00121	CcSEcCtD
Guanfacine—Tachycardia—Sibutramine—obesity	6.91e-05	0.00121	CcSEcCtD
Guanfacine—Hyperhidrosis—Sibutramine—obesity	6.84e-05	0.0012	CcSEcCtD
Guanfacine—Malaise—Bupropion—obesity	6.82e-05	0.00119	CcSEcCtD
Guanfacine—Vertigo—Bupropion—obesity	6.79e-05	0.00119	CcSEcCtD
Guanfacine—Syncope—Bupropion—obesity	6.78e-05	0.00118	CcSEcCtD
Guanfacine—Palpitations—Bupropion—obesity	6.68e-05	0.00117	CcSEcCtD
Guanfacine—Musculoskeletal discomfort—Orlistat—obesity	6.66e-05	0.00116	CcSEcCtD
Guanfacine—Loss of consciousness—Bupropion—obesity	6.64e-05	0.00116	CcSEcCtD
Guanfacine—Abdominal discomfort—Topiramate—obesity	6.63e-05	0.00116	CcSEcCtD
Guanfacine—Insomnia—Orlistat—obesity	6.61e-05	0.00116	CcSEcCtD
Guanfacine—Hypotension—Sibutramine—obesity	6.61e-05	0.00116	CcSEcCtD
Guanfacine—Paraesthesia—Orlistat—obesity	6.57e-05	0.00115	CcSEcCtD
Guanfacine—Convulsion—Bupropion—obesity	6.55e-05	0.00114	CcSEcCtD
Guanfacine—Hypertension—Bupropion—obesity	6.53e-05	0.00114	CcSEcCtD
Guanfacine—Musculoskeletal discomfort—Sibutramine—obesity	6.45e-05	0.00113	CcSEcCtD
Guanfacine—Dyspepsia—Orlistat—obesity	6.44e-05	0.00112	CcSEcCtD
Guanfacine—Myalgia—Bupropion—obesity	6.44e-05	0.00112	CcSEcCtD
Guanfacine—Chest pain—Bupropion—obesity	6.44e-05	0.00112	CcSEcCtD
Guanfacine—Arthralgia—Bupropion—obesity	6.44e-05	0.00112	CcSEcCtD
Guanfacine—Anxiety—Bupropion—obesity	6.41e-05	0.00112	CcSEcCtD
Guanfacine—Insomnia—Sibutramine—obesity	6.4e-05	0.00112	CcSEcCtD
Guanfacine—Pollakiuria—Topiramate—obesity	6.39e-05	0.00112	CcSEcCtD
Guanfacine—Erectile dysfunction—Topiramate—obesity	6.37e-05	0.00111	CcSEcCtD
Guanfacine—Discomfort—Bupropion—obesity	6.36e-05	0.00111	CcSEcCtD
Guanfacine—Decreased appetite—Orlistat—obesity	6.36e-05	0.00111	CcSEcCtD
Guanfacine—Paraesthesia—Sibutramine—obesity	6.35e-05	0.00111	CcSEcCtD
Guanfacine—Dyspnoea—Sibutramine—obesity	6.31e-05	0.0011	CcSEcCtD
Guanfacine—Fatigue—Orlistat—obesity	6.3e-05	0.0011	CcSEcCtD
Guanfacine—Dry mouth—Bupropion—obesity	6.29e-05	0.0011	CcSEcCtD
Guanfacine—Somnolence—Sibutramine—obesity	6.29e-05	0.0011	CcSEcCtD
Guanfacine—Weight increased—Topiramate—obesity	6.29e-05	0.0011	CcSEcCtD
Guanfacine—Dyspepsia—Sibutramine—obesity	6.23e-05	0.00109	CcSEcCtD
Guanfacine—Confusional state—Bupropion—obesity	6.22e-05	0.00109	CcSEcCtD
Guanfacine—Oedema—Bupropion—obesity	6.17e-05	0.00108	CcSEcCtD
Guanfacine—Decreased appetite—Sibutramine—obesity	6.15e-05	0.00108	CcSEcCtD
Guanfacine—Shock—Bupropion—obesity	6.07e-05	0.00106	CcSEcCtD
Guanfacine—Constipation—Sibutramine—obesity	6.05e-05	0.00106	CcSEcCtD
Guanfacine—Feeling abnormal—Orlistat—obesity	6.03e-05	0.00105	CcSEcCtD
Guanfacine—Tachycardia—Bupropion—obesity	6.02e-05	0.00105	CcSEcCtD
Guanfacine—Conjunctivitis—Topiramate—obesity	5.99e-05	0.00105	CcSEcCtD
Guanfacine—Gastrointestinal pain—Orlistat—obesity	5.98e-05	0.00105	CcSEcCtD
Guanfacine—Hyperhidrosis—Bupropion—obesity	5.96e-05	0.00104	CcSEcCtD
Guanfacine—Feeling abnormal—Sibutramine—obesity	5.83e-05	0.00102	CcSEcCtD
Guanfacine—Gastrointestinal pain—Sibutramine—obesity	5.79e-05	0.00101	CcSEcCtD
Guanfacine—Abdominal pain—Orlistat—obesity	5.78e-05	0.00101	CcSEcCtD
Guanfacine—Hypotension—Bupropion—obesity	5.76e-05	0.00101	CcSEcCtD
Guanfacine—Bradycardia—Topiramate—obesity	5.63e-05	0.000984	CcSEcCtD
Guanfacine—Musculoskeletal discomfort—Bupropion—obesity	5.62e-05	0.000982	CcSEcCtD
Guanfacine—Abdominal pain—Sibutramine—obesity	5.59e-05	0.000978	CcSEcCtD
Guanfacine—Insomnia—Bupropion—obesity	5.58e-05	0.000975	CcSEcCtD
Guanfacine—Rhinitis—Topiramate—obesity	5.55e-05	0.000969	CcSEcCtD
Guanfacine—Paraesthesia—Bupropion—obesity	5.54e-05	0.000968	CcSEcCtD
Guanfacine—Hallucination—Topiramate—obesity	5.5e-05	0.000962	CcSEcCtD
Guanfacine—Dyspnoea—Bupropion—obesity	5.5e-05	0.000961	CcSEcCtD
Guanfacine—Somnolence—Bupropion—obesity	5.48e-05	0.000959	CcSEcCtD
Guanfacine—Dyspepsia—Bupropion—obesity	5.43e-05	0.000949	CcSEcCtD
Guanfacine—Hypersensitivity—Orlistat—obesity	5.39e-05	0.000942	CcSEcCtD
Guanfacine—Decreased appetite—Bupropion—obesity	5.36e-05	0.000937	CcSEcCtD
Guanfacine—Visual impairment—Topiramate—obesity	5.33e-05	0.000932	CcSEcCtD
Guanfacine—Fatigue—Bupropion—obesity	5.32e-05	0.00093	CcSEcCtD
Guanfacine—Constipation—Bupropion—obesity	5.28e-05	0.000922	CcSEcCtD
Guanfacine—Asthenia—Orlistat—obesity	5.25e-05	0.000917	CcSEcCtD
Guanfacine—Hypersensitivity—Sibutramine—obesity	5.21e-05	0.000911	CcSEcCtD
Guanfacine—Pruritus—Orlistat—obesity	5.17e-05	0.000904	CcSEcCtD
Guanfacine—Eye disorder—Topiramate—obesity	5.17e-05	0.000904	CcSEcCtD
Guanfacine—Tinnitus—Topiramate—obesity	5.16e-05	0.000902	CcSEcCtD
Guanfacine—Feeling abnormal—Bupropion—obesity	5.08e-05	0.000889	CcSEcCtD
Guanfacine—Asthenia—Sibutramine—obesity	5.08e-05	0.000887	CcSEcCtD
Guanfacine—Gastrointestinal pain—Bupropion—obesity	5.04e-05	0.000882	CcSEcCtD
Guanfacine—Pruritus—Sibutramine—obesity	5.01e-05	0.000875	CcSEcCtD
Guanfacine—Diarrhoea—Orlistat—obesity	5e-05	0.000874	CcSEcCtD
Guanfacine—Immune system disorder—Topiramate—obesity	5e-05	0.000873	CcSEcCtD
Guanfacine—Alopecia—Topiramate—obesity	4.89e-05	0.000854	CcSEcCtD
Guanfacine—Abdominal pain—Bupropion—obesity	4.88e-05	0.000852	CcSEcCtD
Guanfacine—Diarrhoea—Sibutramine—obesity	4.84e-05	0.000846	CcSEcCtD
Guanfacine—Dizziness—Orlistat—obesity	4.84e-05	0.000845	CcSEcCtD
Guanfacine—Tension—Topiramate—obesity	4.73e-05	0.000826	CcSEcCtD
Guanfacine—Dysgeusia—Topiramate—obesity	4.72e-05	0.000824	CcSEcCtD
Guanfacine—Dizziness—Sibutramine—obesity	4.68e-05	0.000818	CcSEcCtD
Guanfacine—Nervousness—Topiramate—obesity	4.68e-05	0.000818	CcSEcCtD
Guanfacine—Vomiting—Orlistat—obesity	4.65e-05	0.000813	CcSEcCtD
Guanfacine—Muscle spasms—Topiramate—obesity	4.63e-05	0.000809	CcSEcCtD
Guanfacine—Rash—Orlistat—obesity	4.61e-05	0.000806	CcSEcCtD
Guanfacine—Dermatitis—Orlistat—obesity	4.61e-05	0.000805	CcSEcCtD
Guanfacine—Headache—Orlistat—obesity	4.58e-05	0.000801	CcSEcCtD
Guanfacine—Hypersensitivity—Bupropion—obesity	4.55e-05	0.000794	CcSEcCtD
Guanfacine—Vision blurred—Topiramate—obesity	4.54e-05	0.000793	CcSEcCtD
Guanfacine—Tremor—Topiramate—obesity	4.51e-05	0.000789	CcSEcCtD
Guanfacine—Vomiting—Sibutramine—obesity	4.5e-05	0.000786	CcSEcCtD
Guanfacine—Ill-defined disorder—Topiramate—obesity	4.47e-05	0.000781	CcSEcCtD
Guanfacine—Rash—Sibutramine—obesity	4.46e-05	0.00078	CcSEcCtD
Guanfacine—Dermatitis—Sibutramine—obesity	4.46e-05	0.000779	CcSEcCtD
Guanfacine—Headache—Sibutramine—obesity	4.43e-05	0.000775	CcSEcCtD
Guanfacine—Asthenia—Bupropion—obesity	4.43e-05	0.000774	CcSEcCtD
Guanfacine—Agitation—Topiramate—obesity	4.43e-05	0.000774	CcSEcCtD
Guanfacine—Pruritus—Bupropion—obesity	4.36e-05	0.000763	CcSEcCtD
Guanfacine—Nausea—Orlistat—obesity	4.34e-05	0.000759	CcSEcCtD
Guanfacine—Malaise—Topiramate—obesity	4.34e-05	0.000759	CcSEcCtD
Guanfacine—Vertigo—Topiramate—obesity	4.33e-05	0.000756	CcSEcCtD
Guanfacine—Syncope—Topiramate—obesity	4.32e-05	0.000755	CcSEcCtD
Guanfacine—Palpitations—Topiramate—obesity	4.26e-05	0.000744	CcSEcCtD
Guanfacine—Loss of consciousness—Topiramate—obesity	4.23e-05	0.00074	CcSEcCtD
Guanfacine—Diarrhoea—Bupropion—obesity	4.22e-05	0.000738	CcSEcCtD
Guanfacine—Nausea—Sibutramine—obesity	4.2e-05	0.000735	CcSEcCtD
Guanfacine—Convulsion—Topiramate—obesity	4.17e-05	0.000729	CcSEcCtD
Guanfacine—Hypertension—Topiramate—obesity	4.16e-05	0.000727	CcSEcCtD
Guanfacine—Chest pain—Topiramate—obesity	4.1e-05	0.000717	CcSEcCtD
Guanfacine—Arthralgia—Topiramate—obesity	4.1e-05	0.000717	CcSEcCtD
Guanfacine—Myalgia—Topiramate—obesity	4.1e-05	0.000717	CcSEcCtD
Guanfacine—Anxiety—Topiramate—obesity	4.09e-05	0.000714	CcSEcCtD
Guanfacine—Dizziness—Bupropion—obesity	4.08e-05	0.000713	CcSEcCtD
Guanfacine—Discomfort—Topiramate—obesity	4.05e-05	0.000708	CcSEcCtD
Guanfacine—Dry mouth—Topiramate—obesity	4.01e-05	0.000701	CcSEcCtD
Guanfacine—Confusional state—Topiramate—obesity	3.96e-05	0.000693	CcSEcCtD
Guanfacine—Diclofenac—CYP2E1—obesity	3.95e-05	0.462	CrCbGaD
Guanfacine—Oedema—Topiramate—obesity	3.93e-05	0.000687	CcSEcCtD
Guanfacine—Vomiting—Bupropion—obesity	3.92e-05	0.000686	CcSEcCtD
Guanfacine—Rash—Bupropion—obesity	3.89e-05	0.00068	CcSEcCtD
Guanfacine—Dermatitis—Bupropion—obesity	3.89e-05	0.000679	CcSEcCtD
Guanfacine—Shock—Topiramate—obesity	3.87e-05	0.000676	CcSEcCtD
Guanfacine—Headache—Bupropion—obesity	3.86e-05	0.000676	CcSEcCtD
Guanfacine—Tachycardia—Topiramate—obesity	3.84e-05	0.00067	CcSEcCtD
Guanfacine—Hyperhidrosis—Topiramate—obesity	3.8e-05	0.000664	CcSEcCtD
Guanfacine—Hypotension—Topiramate—obesity	3.67e-05	0.000642	CcSEcCtD
Guanfacine—Nausea—Bupropion—obesity	3.66e-05	0.00064	CcSEcCtD
Guanfacine—Musculoskeletal discomfort—Topiramate—obesity	3.58e-05	0.000626	CcSEcCtD
Guanfacine—Insomnia—Topiramate—obesity	3.56e-05	0.000621	CcSEcCtD
Guanfacine—Paraesthesia—Topiramate—obesity	3.53e-05	0.000617	CcSEcCtD
Guanfacine—Dyspnoea—Topiramate—obesity	3.5e-05	0.000612	CcSEcCtD
Guanfacine—Somnolence—Topiramate—obesity	3.49e-05	0.000611	CcSEcCtD
Guanfacine—Dyspepsia—Topiramate—obesity	3.46e-05	0.000605	CcSEcCtD
Guanfacine—Decreased appetite—Topiramate—obesity	3.42e-05	0.000597	CcSEcCtD
Guanfacine—Fatigue—Topiramate—obesity	3.39e-05	0.000592	CcSEcCtD
Guanfacine—Constipation—Topiramate—obesity	3.36e-05	0.000587	CcSEcCtD
Guanfacine—Feeling abnormal—Topiramate—obesity	3.24e-05	0.000566	CcSEcCtD
Guanfacine—Gastrointestinal pain—Topiramate—obesity	3.21e-05	0.000562	CcSEcCtD
Guanfacine—Abdominal pain—Topiramate—obesity	3.11e-05	0.000543	CcSEcCtD
Guanfacine—Hypersensitivity—Topiramate—obesity	2.9e-05	0.000506	CcSEcCtD
Guanfacine—Asthenia—Topiramate—obesity	2.82e-05	0.000493	CcSEcCtD
Guanfacine—Pruritus—Topiramate—obesity	2.78e-05	0.000486	CcSEcCtD
Guanfacine—Diarrhoea—Topiramate—obesity	2.69e-05	0.00047	CcSEcCtD
Guanfacine—Dizziness—Topiramate—obesity	2.6e-05	0.000454	CcSEcCtD
Guanfacine—Vomiting—Topiramate—obesity	2.5e-05	0.000437	CcSEcCtD
Guanfacine—Rash—Topiramate—obesity	2.48e-05	0.000433	CcSEcCtD
Guanfacine—Dermatitis—Topiramate—obesity	2.48e-05	0.000433	CcSEcCtD
Guanfacine—Headache—Topiramate—obesity	2.46e-05	0.00043	CcSEcCtD
Guanfacine—Diclofenac—PTGS2—obesity	2.44e-05	0.285	CrCbGaD
Guanfacine—Nausea—Topiramate—obesity	2.33e-05	0.000408	CcSEcCtD
Guanfacine—Diclofenac—ALB—obesity	2.17e-05	0.254	CrCbGaD
Guanfacine—ADRA2A—Signaling Pathways—GNB3—obesity	2.12e-06	7.94e-05	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—CAV1—obesity	2.11e-06	7.92e-05	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—obesity	2.11e-06	7.9e-05	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—APOA1—obesity	2.1e-06	7.9e-05	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3R1—obesity	2.1e-06	7.88e-05	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—HK1—obesity	2.1e-06	7.87e-05	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—SREBF2—obesity	2.1e-06	7.87e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling by GPCR—TYK2—obesity	2.09e-06	7.83e-05	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism—FASN—obesity	2.08e-06	7.82e-05	CbGpPWpGaD
Guanfacine—ADRA2A—GPCR downstream signaling—PIK3CB—obesity	2.08e-06	7.81e-05	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism—SLC2A4—obesity	2.08e-06	7.81e-05	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism—GCG—obesity	2.08e-06	7.81e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—IGF2—obesity	2.08e-06	7.8e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Metabolism—MTHFR—obesity	2.07e-06	7.79e-05	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism—BCHE—obesity	2.07e-06	7.78e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling by GPCR—RHOA—obesity	2.07e-06	7.77e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—GNAS—obesity	2.06e-06	7.73e-05	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism—CYCS—obesity	2.05e-06	7.71e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling by GPCR—PIK3R1—obesity	2.05e-06	7.69e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Metabolism—PPARA—obesity	2.04e-06	7.64e-05	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—ESR1—obesity	2.03e-06	7.63e-05	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—LPA—obesity	2.03e-06	7.6e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—APOB—obesity	2.02e-06	7.57e-05	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism—GOT1—obesity	2.02e-06	7.56e-05	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism—GGT1—obesity	2.02e-06	7.56e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Hemostasis—PIK3CA—obesity	2.01e-06	7.54e-05	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—F2—obesity	2.01e-06	7.53e-05	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—PRKCB—obesity	2.01e-06	7.53e-05	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism—CYP2E1—obesity	2e-06	7.51e-05	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism—NCOA1—obesity	1.98e-06	7.45e-05	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—BAD—obesity	1.98e-06	7.44e-05	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—LPIN1—obesity	1.98e-06	7.44e-05	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism—NQO1—obesity	1.98e-06	7.43e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Metabolism—AGT—obesity	1.97e-06	7.4e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—CCL5—obesity	1.97e-06	7.4e-05	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism—STK11—obesity	1.96e-06	7.34e-05	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism—CYP19A1—obesity	1.96e-06	7.34e-05	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—APOA5—obesity	1.94e-06	7.29e-05	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—obesity	1.94e-06	7.27e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Metabolism—APOE—obesity	1.93e-06	7.25e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—LPL—obesity	1.93e-06	7.23e-05	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—PIK3CG—obesity	1.92e-06	7.21e-05	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—obesity	1.92e-06	7.2e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Metabolism—CAV1—obesity	1.91e-06	7.18e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—FOXO1—obesity	1.91e-06	7.18e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—RPS6KB1—obesity	1.91e-06	7.17e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Metabolism—APOA1—obesity	1.91e-06	7.17e-05	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—IRS1—obesity	1.9e-06	7.13e-05	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism—GCG—obesity	1.9e-06	7.12e-05	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism—SLC2A4—obesity	1.9e-06	7.12e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling by GPCR—PIK3CB—obesity	1.89e-06	7.1e-05	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism—CYCS—obesity	1.87e-06	7.03e-05	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—SLC22A1—obesity	1.85e-06	6.95e-05	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—CLOCK—obesity	1.85e-06	6.95e-05	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism—GGT1—obesity	1.84e-06	6.89e-05	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism—GOT1—obesity	1.84e-06	6.89e-05	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—POMC—obesity	1.83e-06	6.86e-05	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—INS—obesity	1.82e-06	6.82e-05	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism—COMT—obesity	1.82e-06	6.82e-05	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism—NCOA1—obesity	1.81e-06	6.79e-05	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—GLP1R—obesity	1.81e-06	6.77e-05	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—SULT2A1—obesity	1.81e-06	6.77e-05	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism—PPARGC1A—obesity	1.79e-06	6.73e-05	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism—GNB3—obesity	1.79e-06	6.73e-05	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—CCL2—obesity	1.79e-06	6.71e-05	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism—HMOX1—obesity	1.79e-06	6.7e-05	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism—STK11—obesity	1.78e-06	6.69e-05	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism—CYP19A1—obesity	1.78e-06	6.69e-05	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—DPYD—obesity	1.78e-06	6.66e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—PRKCD—obesity	1.78e-06	6.66e-05	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—IGF1—obesity	1.76e-06	6.6e-05	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—AKT2—obesity	1.76e-06	6.6e-05	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism—GNAS—obesity	1.75e-06	6.55e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Metabolism—PIK3CG—obesity	1.74e-06	6.54e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—HTR2A—obesity	1.74e-06	6.52e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—C3—obesity	1.74e-06	6.51e-05	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism—APOB—obesity	1.71e-06	6.42e-05	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—PRKAR2B—obesity	1.71e-06	6.41e-05	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—DCN—obesity	1.7e-06	6.37e-05	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—PIK3CD—obesity	1.69e-06	6.34e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Metabolism—PPARG—obesity	1.68e-06	6.31e-05	CbGpPWpGaD
Guanfacine—ADRA2B—GPCR downstream signaling—PIK3CA—obesity	1.67e-06	6.28e-05	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—SERPINE1—obesity	1.67e-06	6.27e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Metabolism—POMC—obesity	1.66e-06	6.23e-05	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism—COMT—obesity	1.66e-06	6.22e-05	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—CPT1A—obesity	1.65e-06	6.2e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—IRS2—obesity	1.65e-06	6.19e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Metabolism—INS—obesity	1.65e-06	6.19e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—AGT—obesity	1.65e-06	6.19e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Hemostasis—AKT1—obesity	1.64e-06	6.16e-05	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism—PPARGC1A—obesity	1.64e-06	6.14e-05	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism—GNB3—obesity	1.64e-06	6.14e-05	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism—LPL—obesity	1.63e-06	6.13e-05	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism—HMOX1—obesity	1.63e-06	6.11e-05	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—TYK2—obesity	1.62e-06	6.1e-05	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—NAMPT—obesity	1.62e-06	6.08e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—APOE—obesity	1.62e-06	6.06e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—LEP—obesity	1.62e-06	6.06e-05	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—RHOA—obesity	1.61e-06	6.05e-05	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—LIPC—obesity	1.61e-06	6.04e-05	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—GCK—obesity	1.61e-06	6.04e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—CAV1—obesity	1.6e-06	6.01e-05	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—APOC3—obesity	1.6e-06	6e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—APOA1—obesity	1.6e-06	5.99e-05	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—PIK3R1—obesity	1.59e-06	5.98e-05	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—NOS3—obesity	1.59e-06	5.98e-05	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism—GPX1—obesity	1.59e-06	5.98e-05	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism—GNAS—obesity	1.59e-06	5.97e-05	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism—APOB—obesity	1.56e-06	5.85e-05	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—CETP—obesity	1.55e-06	5.82e-05	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism—CD36—obesity	1.55e-06	5.82e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—ESR1—obesity	1.54e-06	5.79e-05	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—SDC1—obesity	1.53e-06	5.76e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Metabolism—PIK3CD—obesity	1.53e-06	5.75e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—F2—obesity	1.52e-06	5.72e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—PRKCB—obesity	1.52e-06	5.72e-05	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling by GPCR—PIK3CA—obesity	1.52e-06	5.7e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Metabolism—ALB—obesity	1.51e-06	5.68e-05	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—AKR1C3—obesity	1.51e-06	5.67e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—BAD—obesity	1.51e-06	5.65e-05	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism—LPL—obesity	1.49e-06	5.59e-05	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—SCARB1—obesity	1.49e-06	5.58e-05	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—MTOR—obesity	1.47e-06	5.52e-05	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—PIK3CB—obesity	1.47e-06	5.52e-05	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism—MTHFR—obesity	1.47e-06	5.52e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—PIK3CG—obesity	1.46e-06	5.47e-05	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism—GPX1—obesity	1.45e-06	5.45e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Metabolism—PIK3R1—obesity	1.45e-06	5.43e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Metabolism—NOS3—obesity	1.45e-06	5.43e-05	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—SREBF1—obesity	1.44e-06	5.42e-05	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism—PPARA—obesity	1.44e-06	5.41e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—IRS1—obesity	1.44e-06	5.41e-05	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism—CD36—obesity	1.41e-06	5.31e-05	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—GOT2—obesity	1.4e-06	5.27e-05	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism—AGT—obesity	1.4e-06	5.24e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—POMC—obesity	1.39e-06	5.21e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—INS—obesity	1.38e-06	5.18e-05	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—FASN—obesity	1.37e-06	5.15e-05	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism—APOE—obesity	1.37e-06	5.14e-05	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—BCHE—obesity	1.37e-06	5.13e-05	CbGpPWpGaD
Guanfacine—ADRA2B—GPCR downstream signaling—AKT1—obesity	1.37e-06	5.13e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—CCL2—obesity	1.36e-06	5.09e-05	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism—CAV1—obesity	1.36e-06	5.09e-05	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism—APOA1—obesity	1.35e-06	5.08e-05	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling by GPCR—IL6—obesity	1.35e-06	5.05e-05	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism—MTHFR—obesity	1.34e-06	5.03e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Metabolism—PIK3CB—obesity	1.34e-06	5.01e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—IGF1—obesity	1.33e-06	5.01e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—AKT2—obesity	1.33e-06	5e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Metabolism—PTGS2—obesity	1.32e-06	4.97e-05	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—CYP2E1—obesity	1.32e-06	4.95e-05	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism—PPARA—obesity	1.32e-06	4.93e-05	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—NQO1—obesity	1.31e-06	4.9e-05	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—obesity	1.3e-06	4.86e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—PIK3CD—obesity	1.28e-06	4.81e-05	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—MMP9—obesity	1.28e-06	4.8e-05	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism—AGT—obesity	1.27e-06	4.78e-05	CbGpPWpGaD
Guanfacine—ADRA2A—GPCR downstream signaling—PIK3CA—obesity	1.27e-06	4.76e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—SERPINE1—obesity	1.27e-06	4.76e-05	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—GCG—obesity	1.25e-06	4.7e-05	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—SLC2A4—obesity	1.25e-06	4.7e-05	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism—APOE—obesity	1.25e-06	4.68e-05	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—MAPK8—obesity	1.24e-06	4.67e-05	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling by GPCR—AKT1—obesity	1.24e-06	4.66e-05	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism—CAV1—obesity	1.24e-06	4.64e-05	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism—PIK3CG—obesity	1.24e-06	4.63e-05	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—CYCS—obesity	1.23e-06	4.63e-05	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism—APOA1—obesity	1.23e-06	4.63e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—TYK2—obesity	1.23e-06	4.63e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—RHOA—obesity	1.22e-06	4.59e-05	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—GGT1—obesity	1.21e-06	4.55e-05	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—GOT1—obesity	1.21e-06	4.55e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—NOS3—obesity	1.21e-06	4.54e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—PIK3R1—obesity	1.21e-06	4.54e-05	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—NCOA1—obesity	1.19e-06	4.48e-05	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism—PPARG—obesity	1.19e-06	4.47e-05	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—obesity	1.18e-06	4.43e-05	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—STK11—obesity	1.18e-06	4.41e-05	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—CYP19A1—obesity	1.18e-06	4.41e-05	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism—POMC—obesity	1.18e-06	4.41e-05	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism—INS—obesity	1.17e-06	4.39e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling by GPCR—PIK3CA—obesity	1.15e-06	4.33e-05	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—STAT3—obesity	1.14e-06	4.27e-05	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism—PIK3CG—obesity	1.13e-06	4.23e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—MTOR—obesity	1.12e-06	4.19e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—PIK3CB—obesity	1.12e-06	4.19e-05	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—COMT—obesity	1.09e-06	4.1e-05	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism—PPARG—obesity	1.09e-06	4.08e-05	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism—PIK3CD—obesity	1.09e-06	4.07e-05	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—PPARGC1A—obesity	1.08e-06	4.05e-05	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—GNB3—obesity	1.08e-06	4.05e-05	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—HMOX1—obesity	1.07e-06	4.03e-05	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism—POMC—obesity	1.07e-06	4.02e-05	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism—ALB—obesity	1.07e-06	4.02e-05	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism—INS—obesity	1.07e-06	4e-05	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—MYC—obesity	1.06e-06	3.97e-05	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—TGFB1—obesity	1.05e-06	3.96e-05	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—GNAS—obesity	1.05e-06	3.94e-05	CbGpPWpGaD
Guanfacine—ADRA2A—GPCR downstream signaling—AKT1—obesity	1.04e-06	3.89e-05	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—APOB—obesity	1.03e-06	3.86e-05	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism—PIK3R1—obesity	1.03e-06	3.85e-05	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism—NOS3—obesity	1.03e-06	3.85e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling by GPCR—IL6—obesity	1.02e-06	3.83e-05	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism—PIK3CD—obesity	9.9e-07	3.72e-05	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—LPL—obesity	9.82e-07	3.68e-05	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism—ALB—obesity	9.77e-07	3.67e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—MMP9—obesity	9.71e-07	3.64e-05	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—GPX1—obesity	9.58e-07	3.59e-05	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism—PIK3CB—obesity	9.46e-07	3.55e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—MAPK8—obesity	9.44e-07	3.54e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling by GPCR—AKT1—obesity	9.42e-07	3.53e-05	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism—PTGS2—obesity	9.38e-07	3.52e-05	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism—PIK3R1—obesity	9.35e-07	3.51e-05	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism—NOS3—obesity	9.35e-07	3.51e-05	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—CD36—obesity	9.33e-07	3.5e-05	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—PIK3CA—obesity	8.97e-07	3.37e-05	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—MTHFR—obesity	8.84e-07	3.32e-05	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—PPARA—obesity	8.67e-07	3.25e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—STAT3—obesity	8.63e-07	3.24e-05	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism—PIK3CB—obesity	8.63e-07	3.24e-05	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism—PTGS2—obesity	8.55e-07	3.21e-05	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—AGT—obesity	8.4e-07	3.15e-05	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—APOE—obesity	8.23e-07	3.09e-05	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—CAV1—obesity	8.15e-07	3.06e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Metabolism—PIK3CA—obesity	8.14e-07	3.06e-05	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—APOA1—obesity	8.14e-07	3.05e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—MYC—obesity	8.02e-07	3.01e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—TGFB1—obesity	8e-07	3e-05	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—IL6—obesity	7.95e-07	2.98e-05	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—PIK3CG—obesity	7.43e-07	2.79e-05	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—AKT1—obesity	7.33e-07	2.75e-05	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—PPARG—obesity	7.17e-07	2.69e-05	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—POMC—obesity	7.07e-07	2.65e-05	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—INS—obesity	7.03e-07	2.64e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—PIK3CA—obesity	6.81e-07	2.56e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Metabolism—AKT1—obesity	6.65e-07	2.5e-05	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—PIK3CD—obesity	6.53e-07	2.45e-05	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—ALB—obesity	6.45e-07	2.42e-05	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—PIK3R1—obesity	6.17e-07	2.31e-05	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—NOS3—obesity	6.17e-07	2.31e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—IL6—obesity	6.03e-07	2.26e-05	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism—PIK3CA—obesity	5.77e-07	2.16e-05	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—PIK3CB—obesity	5.69e-07	2.14e-05	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—PTGS2—obesity	5.64e-07	2.12e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—AKT1—obesity	5.56e-07	2.09e-05	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism—PIK3CA—obesity	5.26e-07	1.97e-05	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism—AKT1—obesity	4.71e-07	1.77e-05	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism—AKT1—obesity	4.3e-07	1.61e-05	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—PIK3CA—obesity	3.47e-07	1.3e-05	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—AKT1—obesity	2.83e-07	1.06e-05	CbGpPWpGaD
